Introduction {#s1}
============

Parkinson\'s disease (PD) is one of the most common neurodegenerative diseases, affecting \~2% of people over the age of 60 years, and the most common cause of movement disorders, including bradykinesia, resting tremor, rigidity, and postural instability or gait difficulty. Non-motor symptoms, such as depression, olfactory dysfunction, and constipation are also common in PD (Schapira, [@B82]). The pathological hallmark of PD is Lewy Body aggregation in neurons and the loss of dopamine neurons in the substantia nigra compacta and corpus striatum.

The pathogenesis of PD is as yet unclear, but genetic and environmental factors, as well as aging are thought to contribute to PD risk. Since the discovery of the *PARK1* locus, further autosomal-dominant or -recessive disease genes have been identified (Paisan-Ruiz, [@B74]). The most common among the former is the leucine-rich repeat kinase 2 (*LRRK2*) gene, which encodes for a protein containing armadillo (ARM), Ras of complex proteins (ROC), C-terminal of ROC (COR), mitogen-activated protein kinase kinase kinase (MAPKKK), and WD40 domains, in addition to others (Kruger, [@B53]).

To date, nearly a hundred *LRRK2* variants have been identified. Of these, G2019S, R1628P, and G2385R have traditionally received much of the attention, and there have already been a number of meta-analyses on the role of these variants in PD risk in people of different ethnicities (Xie et al., [@B101]; Liu et al., [@B63]; Zhang et al., [@B109]; Zhao and Kong, [@B113]). These variants each possess distinct geographical distributions. G2019S, which is the most frequently-occurring variant, accounts for 3--6% of familial PD cases among patients in European populations (Guo et al., [@B40]) and nearly 14% of Ashkenazi Jews (AJ) (Luzon-Toro et al., [@B65]), whereas G2385R and R1628P were found to be more common among East Asian PD patients (Fu et al., [@B30]).

If strict selection criteria and quality control methods are employed, meta-analysis can be an immensely powerful tool, allowing researchers to pool data from original studies and effectively expanding the sample size (Haines et al., [@B41]) to provide unbiased evidence with far-reaching clinical implications (Wolf, [@B97]). In the case of genetic analyses in particular, where original studies are inevitably limited by the diversity of their subject pool, and by their limited sample sizes a meta-analytical approach can be invaluable in providing convincing evidence for the effects of a specific gene on disease risks. In the recent crop of articles, researchers have begun to shift their focus to the other less well-known *LRRK2* variants. Given that others have not yet done so, we decided in this study to perform a complete analysis of all relevant original association studies relating to the *LRRK2* variants that have been identified thus far.

Methods {#s2}
=======

Literature Search
-----------------

The English-language Medline and Embase databases, as well as the Chinese-language Wanfang, CNKI, and VIP databases were searched manually on Nov 29, 2018, using the keywords "parkinson^\*^," "PD," "*LRRK2*," "PARK8," "polymorphisms," "SNP," "gene," "variant," and "mutation." Overlapping articles among databases were deleted in EndNote.

Selection Criteria
------------------

The PICOS (participants, interventions, controls, outcomes, and study types) approach was used to define inclusion criteria. For this study, "participants" were patients diagnosed with PD according to accepted standards, such as the UK PD Society Brain Bank Clinical Diagnostic Criteria (Hughes et al., [@B46]) and other widely accepted criteria (Calne et al., [@B10]; Bower et al., [@B6]; Gelb et al., [@B34]); "Interventions" consisted of gDNA analysis performed using accepted methods based on PCR; "Controls" were people without PD or related diseases (movement disorders, neurodegenerative diseases etc.); We accepted the definition of PD patients or controls by the authors of the original articles if there were no description of the criteria; "Outcomes" were complete data (complete number of patients or controls carrying either homozygous or heterozygous polymorphisms of *LRRK2*) and at least four original articles reported on the same variant, and "study types" consisted of original case-control studies, cohort studies ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}).

Data Extraction
---------------

Complete data, including containing the name of the first author, the publication year of the study, subject ethnicity, the country in which the study was performed, the gene and gene variants analyzed, the number of cases and controls and subject genotypes (both homozygotes and heterozygotes) were extracted from all selected original studies, and are detailed in the [Table 1](#T1){ref-type="table"}, [Supplementary Table 2](#SM2){ref-type="supplementary-material"}. Pooled analysis was performed in cases where sufficient data was provided to allow for the calculation of odds ratios (OR) and 95% confidence intervals (CI). If studies had enough data to calculated frequency of variants, we included the articles in the frequency analysis. Newcastle-Ottawa Scale (NOS) was used to perform quality control on all included studies. Data extraction was performed by Li S and Yuan Z, in consultation with Qiying S. Results relating to R1628P were provided by ZY, a co-author on this study, and were based on (Zhang et al., [@B111]).

###### 

The characteristics of all included publications.

  **References**                        **Ethnicity**          **Country**                **Researched variants**          **PD**   **Controls**   **NOS**
  ------------------------------------- ---------------------- -------------------------- -------------------------------- -------- -------------- ---------
  Tan et al., [@B86]                    East Asians            Singapore                  G2019S                           675      325            8
  Aasly et al., [@B1]                   European/West Asians   Norway                     G2019S                           435      519            7
  Berg et al., [@B5]                    European/West Asians   Germany                    G2019S, R793M                    337      1,200          8
  Bras et al., [@B8]                    European/West Asians   Portugal                   G2019S                           124      126            6
  Gilks et al., [@B35]                  European/West Asians   UK                         G2019S                           482      345            6
  Goldwurm et al., [@B36]               European/West Asians   Italy                      G2019S, R1441C                   629      440            8
  Hernandez et al., [@B44]              European/West Asians   America                    G2019S                           719      2,680          8
  Mata et al., [@B69]                   European/West Asians   Spain                      R1441G                           225      100            7
  Deng et al., [@B22]                   Mixed                  North American             G2019S                           326      130            7
  Farrer et al., [@B26]                 Mixed                  America                    G2019S, R793M                    786      278            7
  Kachergus et al., [@B50]              Mixed                  Europe and North America   G2019S                           1,054    2,260          8
  Nichols et al., [@B71]                Mixed                  North America              G2019S                           767      965            7
  Di Fonzo et al., [@B23]               East Asians            Taiwan                     A419V, G2385R, P755L             592      344            8
  Funayama et al., [@B31]               East Asians            Japan                      G2385R                           448      457            8
  Fung et al., [@B32]                   East Asians            Taiwan                     G2385R                           305      176            7
  Fung et al., [@B33]                   East Asians            Taiwan                     G2019S                           343      213            7
  Punia et al., [@B79]                  East Asians            India                      G2019S                           800      212            7
  Wu et al., [@B98]                     East Asians            China                      P755L                            598      765            8
  Infante et al., [@B48]                European/West Asians   Spain                      G2019S                           105      310            7
  Carmine Belin et al., [@B11]          European/West Asians   Sweden                     G2019S                           284      305            7
  Marongiu et al., [@B67]               European/West Asians   Italy                      G2019S                           1,072    300            8
  Mata et al., [@B68]                   European/West Asians   Spain                      G2019S                           225      100            7
  Pchelina et al., [@B76]               European/West Asians   Russia                     G2019S                           208      161            7
  Schlitter et al., [@B83]              European/West Asians   Germany                    G2019S                           120      336            7
  Williams-Gray et al., [@B96]          European/West Asians   UK                         G2019S                           519      887            8
  Clark et al., [@B18]                  Mixed                  America                    G2019S                           504      314            8
  Deng et al., [@B21]                   Mixed                  North America              G2019S                           496      220            7
  Kay et al., [@B51]                    Mixed                  America                    G2019S                           1,518    1,733          9
  Ozelius et al., [@B73]                Mixed                  America                    G2019S                           120      317            7
  Civitelli et al., [@B17]              European/West Asians   Italy                      G2019S                           488      180            7
  Cossu et al., [@B19]                  European/West Asians   Italy                      G2019S                           98       55             6
  Farrer et al., [@B27]                 East Asians            Taiwan                     G2385R                           410      335            8
  Li et al., [@B57]                     East Asians            China                      G2385R                           235      214            7
  Orr-Urtreger et al., [@B72]           European/West Asians   Israel                     G2019S                           472      1,802          8
  Tan et al., [@B89]                    East Asians            Singapore                  G2385R                           495      494            8
  Tan et al., [@B90]                    East Asians            Singapore                  G2385R                           166      306            7
  Toft et al., [@B91]                   European/West Asians   Norway                     R793M                            433      587            7
  Xiromerisiou et al., [@B102]          European/West Asians   Greece                     G2019S                           290      235            7
  Aguiar Pde et al., [@B2]              Hispanics              Brazil                     G2019S                           72       72             6
  Hulihan et al., [@B47]                African                Tunis                      G2019S                           238      371            7
  An et al., [@B3]                      East Asians            China                      G2385R                           600      334            8
  Choi et al., [@B15]                   East Asians            Korea                      G2385R                           72       100            6
  Chan et al., [@B12]                   East Asians            Hong Kong                  G2385R                           82       31             6
  Lu et al., [@B64]                     East Asians            China                      R1628P                           834      543            8
  Ross et al., [@B81]                   East Asians            Taiwan and Singapore       R1628P                           1,079    907            9
  Tan et al., [@B85]                    East Asians            Singapore                  P755L                            204      235            7
  Tan et al., [@B87]                    East Asians            Singapore                  R1628P                           192      265            7
  Tan et al., [@B88]                    East Asians            Singapore                  R1628P                           246      243            7
  Tomiyama et al., [@B92]               East Asians            Japan                      P755L                            501      583            8
  Bras et al., [@B7]                    European/West Asians   Portugal                   G2019S                           132      126            7
  Floris et al., [@B28]                 European/West Asians   Italy                      G2019S, R1441C                   356      208            7
  Patra et al., [@B75]                  European/West Asians   America                    G2019S                           575      186            7
  Yu et al., [@B107]                    East Asians            China                      R1628P                           328      300            7
  Zabetian et al., [@B108]              East Asians            Japan                      G2019S, G2385R                   631      320            8
  Zhang et al., [@B112]                 East Asians            China                      R1628P                           600      459            8
  Gorostidi et al., [@B38]              European/West Asians   Spain                      G2019S, R1441G                   418      138            7
  Hassin-Baer et al., [@B42]            European/West Asians   Israel                     G2019S                           242      900            7
  Lesage et al., [@B55]                 Mixed                  Europe and North Africa    G2019S                           226      174            7
  Jasinska-Myga et al., [@B49]          African                Tunis                      G2019S                           240      372            7
  Chen et al., [@B13]                   East Asians            China                      R1398H                           430      452            7
  Kim et al., [@B52]                    East Asians            Korea                      G2385R, R1628P                   923      422            8
  Miyake et al., [@B70]                 East Asians            Japan                      G2385R                           229      358            7
  Yescas et al., [@B106]                Hispanics              Mexico                     G2019S                           319      200            7
  Hu et al., [@B45]                     East Asians            China                      G2019S                           221      120            7
  Lin et al., [@B62]                    East Asians            Taiwan                     G2385R, R1628P, S1647T           453      291            7
  Pulkes et al., [@B77]                 East Asians            Thailand                   G2385R, R1628P                   154      156            6
  Yao et al., [@B105]                   East Asians            China                      P755L                            401      398            8
  Zheng et al., [@B114]                 East Asians            China                      S1647T                           406      412            7
  Li et al., [@B59]                     East Asians            China                      A419V                            729      585            8
  Vishwanathan Padmaja et al., [@B93]   East Asians            India                      G2019S                           140      201            7
  Wang et al., [@B94]                   East Asians            China                      R1628P                           2,013    1,971          9
  Yan et al., [@B103]                   East Asians            China                      G2385R                           354      340            8
  Yan et al., [@B104]                   East Asians            China                      S1647T                           354      160            6
  Zhou et al., [@B115]                  East Asians            China                      G2385R, R1628P                   202      212            7
  Cai et al., [@B9]                     East Asians            China                      G2385R, R1628P                   510      550            8
  Fu et al., [@B30]                     East Asians            China                      G2385R, R1628P                   446      403            7
  Gopalai et al., [@B37]                East Asians            Malaysia                   A419V                            404      424            8
  Li B. et al., [@B56]                  East Asians            China                      G2385R                           197      202            6
  Li Z. et al., [@B61]                  East Asians            China                      G2385R                           237      190            6
  Ma et al., [@B66]                     East Asians            China                      G2385R                           237      190            7
  Wu et al., [@B99]                     East Asians            Taiwan                     G2385R, R1398H, R1628P, S1647T   573      503            9
  Wu-Chou et al., [@B100]               East Asians            Taiwan                     G2385R, P755L, R1398H, R1628P    941      618            8
  Chung et al., [@B16]                  East Asians            Korean                     G2385R                           1,032    1,201          8
  Dan et al., [@B20]                    East Asians            China                      G2385R                           561      556            8
  Guo et al., [@B39]                    East Asians            China                      G2385R, R1628P                   1,020    1,031          8
  Pulkes et al., [@B78]                 East Asians            Thailand                   R1628P                           485      480            7
  Chien et al., [@B14]                  Hispanics              Multi-countries            G2019S                           100      100            8
  Heckman et al., [@B43]                East Asians            Multi-countries            R1398H                           1,345    938            9
  Heckman et al., [@B43]                European/West Asians   Multi-countries            R1398H                           5,894    4,282          9
  Li K. et al., [@B58]                  East Asians            China                      A419V                            500      574            7
  Li X.X. et al., [@B60]                East Asians            China                      G2019S                           312      360            7
  Duque et al., [@B24]                  Hispanics              Colombia                   G2019S                           154      162            6
  Bandres-Ciga et al., [@B4]            European/West Asians   Spain                      G2019S, R793M                    240      192            7
  Landoulsi et al., [@B54]              African                Tunis                      G2019S                           250      218            7
  Emelyanov et al., [@B25]              European/West Asians   Russia                     G2019S                           762      400            8

*PD, Parkinson\'s disease*.

Statistical Analysis
--------------------

Statistical analysis was performed using Revman 5.3 software. The pooled analyses were conducted if there were at least four original studies. Meta-analyses were conducted on total populations and subgroup analyses by ethnicity (Africans, European/West Asians, Hispanics, East Asians, mixed:composed of at least two different groups) (Risch et al., [@B80]; Zhang et al., [@B110]). In cases where the Q statistic *P* \> 0.1 and *I*^2^ statistic ≤ 50%, a fixed-effect model was used, otherwise, a random-effect model was applied for pooled analysis instead. All pooled results were graphed using forest plots and publication biases were showed using funnel plots. Subgroup analysis using the Mantel-Haenszel statistical method was performed to determine how the common *LRRK2* variants affect PD risk and the level of significance was set at *p* \< 0.05. Sensitivity analysis was performed by sequentially deleting each included article, and observing how the pooled OR and 95%CI was affected by their removal. Genotype frequency (GF) and minor allele frequency (MAF) were calculated of each *LRRK2* variants in our analyses.

Results {#s3}
=======

A total of 4,439 articles were included following our initial database search ([Figure 1](#F1){ref-type="fig"}). 2,875 articles remained after repeated articles had been eliminated, and a further 2,618 articles were excluded after we had manually reviewed their titles and abstracts. Among the 257 articles that received a full-text review, 163 were excluded due to no controls, functional studies, not original studies, not complete genotyping data, pedigree analysis and articles studying variants with no more than 4 reported articles. Eventually, 94 relevant articles were included in the final analysis, covering 49,299 cases and 47,319 control subjects ([Table 1](#T1){ref-type="table"}). As shown in [Table 1](#T1){ref-type="table"}, all included articles were of high quality. Subgroup analysis was performed for each of the major ethnic groups (Africans, European/West Asians, Hispanics, East Asians, mixed: composed of at least two different groups). Results of the pooled analysis were graphed using forest plots ([Supplementary Figure 1](#SM4){ref-type="supplementary-material"}), and variant frequencies in PD patients of different ethnicities were further calculated ([Figure 2](#F2){ref-type="fig"}). All analysis was performed using a fixed-effect model due to there being relatively little heterogeneity among the included studies.

![Flowchart illustrating the literature screening process.](fnagi-11-00013-g0001){#F1}

![Nine *LRRK2* variants were included in the meta-analysis. **(A)** Six variants which had statistical differences in our pooled analysis. **(B)** Red, blue, and black arrows indicate that the associated variant increases, decreases, or has no bearing on PD risk, respectively. The arrow pointed to MAF of a specific variant.](fnagi-11-00013-g0002){#F2}

Comprehensive Analysis of *LRRK2* Variants in Different Ethnicities
-------------------------------------------------------------------

Based on our comprehensive analysis of the common *LRRK2* variants, we concluded that A419V, R1398H, R1441C/G/H, R1628P, G2019S, and G2385R were associated with greater PD risk (*p*: 0.001, 0.0004, \< 0.00001, \< 0.00001, and \< 0.00001, respectively), while R1398H was associated with decreased PD risk (\< 0.00001; [Figure 2](#F2){ref-type="fig"}). Of the high-risk variants, G2019S posed the greatest degree of risk, followed by R1441C/G/H, A419V, G2385R, and R1628P in descending order, as demonstrated by their OR values, which ranged from 13.16 to 1.83 ([Table 2](#T2){ref-type="table"}).

###### 

Relationship between common *LRRK2* and overall PD risk and for populations of specific ethnicities.

  **Variants**                     **Total population**         **Africans**   **East asians**           **European/west asians**    **Hispanics**   **Mixed**
  -------------------------------- ---------------------------- -------------- ------------------------- --------------------------- --------------- ---------------------------
  A419V                            4 (2,225/1,927)              0 (0/0)        4 (2,225/1,927)           0 (0/0)                     0 (0/0)         0 (0/0)
                                   **2.45 \[1.43, 4.20\]**      NA             **2.45 \[1.43, 4.20\]**   NA                          NA              NA
                                   **0.001**                    NA             **0.001**                 NA                          NA              NA
  P755L                            6 (2,808/2,764)              0 (0/0)        6 (2,808/2,764)           0 (0/0)                     0 (0/0)         0 (0/0)
                                   1.24 \[0.97, 1.59\]          NA             1.24 \[0.97, 1.59\]       NA                          NA              NA
                                   0.09                         NA             0.09                      NA                          NA              NA
  R793M                            4 (1,796/2,257)              0 (0/0)        0 (0/0)                   3 (1,010/1,979)             0 (0/0)         1 (786/278)
                                   0.99 \[0.30, 3.31\]          NA             NA                        NA                          NA              NA
                                   0.99                         NA             NA                        NA                          NA              NA
  R1398H                           5 (8,761/6,609)              0 (0/0)        4 (2,867/2,327)           1 (5,894/4,282)             0 (0/0)         0 (0/0)
                                   **0.81 \[0.75, 0.89\]**      NA             **0.78 \[0.68, 0.90\]**   NA                          NA              NA
                                   **\< 0.00001**               NA             **0.0005**                NA                          NA              NA
  R1441C/G/H                       4 (1,599/711)                0 (0/0)        0 (0/0)                   4 (1,599/711)               0 (0/0)         0 (0/0)
                                   **12.75 \[3.11, 52.27\]**    NA             NA                        **12.75 \[3.11, 52.27\]**   NA              NA
                                   **0.0004**                   NA             NA                        **0.0004**                  NA              NA
  R1628P (Zhang et al., [@B111])   16 (9,275/8,114)             0 (0/0)        16 (9,275/8,114)          0 (0/0)                     0 (0/0)         0 (0/0)
                                   **1.83 \[1.57, 2.13\]**      NA             **1.83 \[1.57, 2.13\]**   NA                          NA              NA
                                   **\< 0.00001**               NA             **\< 0.00001**            NA                          NA              NA
  S1647T                           4 (1,786/1,366)              0 (0/0)        4 (1,786/1,366)           0 (0/0)                     0 (0/0)         0 (0/0)
                                   1.05 \[0.91, 1.21\]          NA             1.05 \[0.91, 1.21\]       NA                          NA              NA
                                   0.54                         NA             0.54                      NA                          NA              NA
  G2019S                           47 (19,624/21,642)           3 (728/961)    7 (3,122/1,751)           24 (9,332/12,005)           3 (545/434)     10 (5,897/6,491)
                                   **13.16 \[10.16, 17.04\]**   NA             1.59 \[0.18, 14.05\]      **8.71 \[6.12, 12.38\]**    NA              **18.12 \[9.26, 35.44\]**
                                   **\< 0.00001**               NA             0.67                      **\< 0.00001**              NA              **\< 0.00001**
  G2385R                           27 (12,121/11,684)           0 (0/0)        27 (12,121/11,684)        0 (0/0)                     0 (0/0)         0 (0/0)
                                   **2.27 \[2.03, 2.53\]**      NA             **2.27 \[2.03, 2.53\]**   NA                          NA              NA
                                   **\< 0.00001**               NA             **\< 0.00001**            NA                          NA              NA

*The number of articles (cases/controls), OR \[95%CI\], and p-value are shown. OR and 95%CI values shown in bold correspond to statistically significant results*.

By ethnicity, our analysis indicated that A419V, R1628P, and G2385R were associated with increased PD risk in East Asian populations (*p*: 0.001, \< 0.00001, and \< 0.00001), while R1398H had the opposite effect (*p*: 0.0005). The G2019S variant was found to increase PD risk in European/West Asian and mixed populations (*p*: \< 0.00001 and \< 0.00001), while R1441C/G/H increased risk for European/West Asians only (*p*: 0.0004; [Table 2](#T2){ref-type="table"}).

*LRRK2* Variant Frequency in PD Patients and Control Individuals of Different Ethnicities
-----------------------------------------------------------------------------------------

Among the *LRRK2* variants which were of statistical significance in previous meta-analyses, the most frequently-occurring *LRRK2* variants in PD patients were, in descending order, R1398H, G2385R, R1628P, and A419V, which had MAF ranging from 0.094 to 0.012 in East Asian populations ([Figure 2](#F2){ref-type="fig"}; [Supplementary Table 3](#SM3){ref-type="supplementary-material"}). In European/West Asians, the MAF of the high-risk variants G2019S and R1441C/G/H were 0.013 and 0.020, respectively ([Figure 2](#F2){ref-type="fig"}; [Supplementary Table 3](#SM3){ref-type="supplementary-material"}), and G2019S occurred within mixed populations at a total frequency of 0.013. Further, we found that A419V, R1628P, and G2385R appeared to be specific for Asian populations, while R1441C/G/H were European/West Asians-specific. Even though the total genotype frequency for other variants, such as S1647T and P755L were higher compared to those of G2385R or G2019S, a significant difference in their distribution between cases and control subjects was not apparent.

Sensitivity Analysis and Publication Bias
-----------------------------------------

After sequentially deleting each included article, the pooled OR and 95% CI of each variant was not changed significantly, and the pooled results of each grouped and subgroup analysis remained stable. Publication biases were not obvious from the funnel plots of all responsive variants ([Supplementary Figure 2](#SM5){ref-type="supplementary-material"}).

Discussion {#s4}
==========

The current meta-analysis and systematic review is, as far as we are aware, the most comprehensive analysis of common *LRRK2* variants in PD to date, and revealed population heterogeneity to be a prominent factor in *LRRK2* allelic distribution.

Previous studies of ethnicity-specific *LRRK2* variation have focused primarily on the common variants G2019S, G2385R, and R1628P (Xie et al., [@B101]; Liu et al., [@B63]; Zhang et al., [@B109]; Zhao and Kong, [@B113]), showing that G2019S was more common in European and North American populations while G2385R and R1628P existed only in Asian populations (Guo et al., [@B40]). Our study replicated these results, and further demonstrated the importance of other variants, such as P755L, A419V, and R1398H. We demonstrated that G2019S, R1441C/G/H, A419V, G2385R, and R1628P, in descending order, carried the highest overall degrees of PD risk, as indicated by their ORs, which ranged from 13.16 to 1.83.

In East Asian populations, G2385R, R1628P, and A419V (arranged in descending order according to the frequency of their occurrence) were found to increase PD risk. Although previous studies have been quite successful at identifying high-frequency risk variants, our findings serve to highlight the fact that even those that occur at lower frequencies, such as A419V, should not be neglected, particularly in East Asian populations, even if clinically significant data may only be accessed in these cases through the use of larger sample sizes that are possible only with collaborative multi-center projects. We also determined that G2019S can increase PD risk in European/West Asian and mixed populations, while R1441C/G/H increases PD risk in European/West Asians only. The pooled analysis and frequency analysis of variants in *LRRK2* supported the differences in geographic distributions of *LRRK2* variants.

The 51-exon *LRRK2* gene has always posed a challenge for researchers interested in screening for the gene due to its large size. For the sake of improving the efficiency and economy of genetic diagnosis, it is thus of great importance to prioritize the identification of specific variations instead of sequencing the entire gene (Foroud, [@B29]). Based on calculations of the ORs associated with each of the *LRRK2* variants, we suggest that A419V, G2385R, and R1628P, and G2019S and R1441C/G/H should be screened for first in East Asians and European/West Asians, respectively. Variants with high OR *and* that occur at higher rates, such as G2385R in East Asian populations and G2019S in European/West Asian populations, should be, in particular, prioritized above all others.

Our meta-analysis also revealed additional details of how mutations affect *LRRK2* function, which could have potential ramifications with regards to our understanding of the mechanisms that underlie PD and the development of future treatment strategies. We determined, for instance, that all of the high-risk variants carried mutations in the exon regions of the *LRRK2* gene, and in the functional domains of the *LRRK2* protein ([Figure 3](#F3){ref-type="fig"}). While the specific pathological mechanisms of these mutations are as yet unclear, it is possible that they can lead to an increase in the kinase activity of the protein, thereby increasing disease risk as well (West et al., [@B95]), as in the case of the G2019S "gain of function" feature (Luzon-Toro et al., [@B65]). If this is demonstrated to be true on a more general basis, it may be promising to target the variations in these vital regions for therapeutic purposes.

![Schematic figure illustrating the distribution of mutations associated with various *LRRK2* variants demonstrated by meta-analysis to have a significant effect on PD risk. Only exons containing these mutations are shown. Note particular variants linked to mutations in functional domains. LRR, leucine rich repeat; ROC, Ras of complex proteins; COR, C-terminal of Roc; MAPKKK, kinase domain of MAPK; WD40, β-propeller.](fnagi-11-00013-g0003){#F3}

Certain *LRRK2* variants appear to be linked with clinical phenotypes. For instance, motor fluctuations were more frequent in the G2385R carriers than in non-carriers in PD patients. G2019S had better olfactory function and less likely to have depression than G2385R carriers (West et al., [@B95]). In a large meta-analysis of LRRK2 related clinical features by our group, we found that *LRRK2*-G2019S-related PD patients were likely to be female, had higher rates of early-onset PD and family history. Moreover, they tended to have high scores of Schwab & England, low Geriatric Depression Scale (GDS) scores, high University of Pennsylvania Smell Identification Test (UPSIT) scores and responded well to Levodopa. G2385R carriers tended to have family history, lower Hoehn and Yahr rating (H-Y) and higher Mini Mental State Examination (MMSE) scores. However, both G2019S and G2385R carriers were more likely to develop motor complications than non-carriers (Shu et al., [@B84]). Therefore, for the purposes of clinical genetic counseling and testing, the symptoms exhibited by the patient could be useful in guiding the decision of which *LRRK2* variant to screen for. Additionally, identifying the specific clinical features associated with carrier of particular *LRRK2* variants could also be useful for neurologists in prescribing the correct symptomatic treatments.

There are, of course, limitations to this study. Firstly, although we have endeavored to include every published case-control study in the meta-analysis, certain pieces of unpublished data, or articles that were written in languages other than English or Chinese may have been omitted unintentionally. Secondly, due to the lack of sufficient data, variants in populations other than East Asians and European/West Asians cannot be analyzed, and it is possible that biases may exist in our pooled analysis of different ethnic groups and in their demographic information, such as age and gender. Thirdly, stratified analysis can inadvertently increase the possibility of there being false positives, especially as the sample size is limited.

Conclusion {#s5}
==========

In conclusion, we found that *LRRK2* variants A419V, G2019S, R1441C/G/H, G2385R, and R1628P were associated with increased PD risk while R1398H was associated with decreased risk. In East Asian populations, A419V, G2385R, and R1628P increased risk, while R1398H had the opposite effect. G2019S increased the risk in European/West Asian and mixed populations while R1441C/G/H increased the risk of PD in European/West Asians. Combined with frequency analysis, we suggest that A419V, G2385R, and R1628P should receive top priority for screening in East Asian populations and that a greater focus be placed on G2019S and R1441C/G/H in European/West Asian populations.
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